Elmind Capital, LP

SEC CIK: 0002052213
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

KALV holding history

KalVista Pharmaceuticals, Inc. in every 13F filed by Elmind Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KALV overview All 13F holders of KALV Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2025

Holdings of KALV by Elmind Capital, LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−1,021,300−100.0%	Sold out	Holders
Q1 2026	1,021,300	$20.6M	5.8%	+220,000+27.5%	Added	Holders
Q4 2025	801,300	$12.9M	3.8%	–	No prior filing	Holders